Chimin(SH:603222) Zheng Quan Zhi Xing·2025-08-15 16:24Core Viewpoint - The stock of Jimin Health Management Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from August 13 to August 15, 2025 [1][2]. Group 1: Stock Trading Abnormality - The stock price fluctuation is classified as an abnormal trading situation according to the Shanghai Stock Exchange trading rules [1]. - The company conducted a self-examination and confirmed that there were no significant changes in its main business or external operating environment, and no undisclosed major matters exist [1][2]. Group 2: Confirmation from Major Stakeholders - Written confirmation from the controlling shareholder and actual controller indicates that, apart from disclosed matters, there are no significant asset restructurings, share issuances, major transactions, business reorganizations, or other major events related to the company [2]. - The board of directors verified that there were no media reports or market rumors that could significantly impact the company's stock price during the abnormal trading period [2]. Group 3: Financial Performance - The company is expected to report a loss of 46 million yuan for the first half of 2025, compared to the same period last year, as disclosed in the half-year performance warning announcement [3]. - The current static price-to-earnings ratio is reported as a loss, while the price-to-book ratio stands at 2.91 [2]. Group 4: Board of Directors' Statement - The board of directors confirmed that there are no undisclosed matters or related plans that should be disclosed according to the Shanghai Stock Exchange listing rules [4].